FROM Charles Rotblut
High Finance and White-Collar Crime Raj Rajaratnam's Galleon Group hedge fund was once worth $7 billion, and he paid ten high-powered lawyers to defend him on charges of insider trading. But a working-class jury found him guilty on all 14 counts , based in large part on telephone conversations with tipsters recorded by federal investigators. After his conviction, the billionaire rolled away from New York's federal courthouse in a silver Mercedes. He's facing prison and fines, but it's not clear what the broader consequences might be. Prosecutors promise an ongoing crackdown on insider trading. Skeptics see Rajaratnam's trial as a road map for how to get away with it. Others ask, what about the bankers accused of causing the Great Recession? Polls show that most Americans think Wall Street is rigged. Will taking down a major player restore the confidence of ordinary investors?
Janesville and the American Dream Janesville, Wisconsin is the hometown of Republican House Speaker Paul Ryan. But he couldn’t prevent the closing of the General Motors factory after 100 years. On this Memorial Day rebroadcast of To the Point, we hear what’s happened to what once was a model of American middle-class unity.
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.